Oh-Biologika-2023-14 - Insulin Isophane/Insulin, Normal (Human) (Combination Of Active Ingredients) (Dosage Form: Cylinder Ampoules)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 66059970

  Document Type - Tender Notices

Description - The health insurance funds involved are pursuing the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130a (8) SGB V for the active ingredient insulin isophane/insulin, normal (human) (combi nation of active ingredients) (dosage form: cylinder ampoules). The contract is concluded as part of the Open House Biologicals process of the health insurance companies involved: Individual negotiations on the content of the contract are not conducted, uniform conditions apply. The cash registers involved do not guarantee individual contractual partners any exclusivity. The contract period is a maximum of 24 months starting on August 1st, 2023.

Gt Ref Id - 66059970

Deadline - Jul 31, 2025